Health Notices




NEW ZEALAND GAZETTE, No. 76

24 APRIL 2008


Health

Crown Entities Act 2004

New Zealand Public Health and Disability Act 2000

Appointments to Whanganui District Health Board

Pursuant to section 29(1)(b) of the New Zealand Public Health and Disability Act 2000, and under section 28(2) of the Crown Entities Act 2004, I appoint

Nancy Te Urumanao Tuaine

as a member of the board of Whanganui District Health Board; and under clause 10(1) of Schedule 3 to the

New Zealand Public Health and Disability Act 2000,
I appoint

Ormond Brian Stock

as deputy chairperson of the board of Whanganui District Health Board.

These appointments take effect on 24 April 2008 and will end on 5 December 2010.

Dated at Wellington this 21st day of April 2008.

HON DAVID CUNLIFFE, Minister of Health.

go2852


Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Apo – Quinapril

Active Ingredient:
Quinapril hydrochloride 10.832mg equivalent to 10mg quinapril

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer:
Lupin Limited, Verna Industrial Area, Verna, Salcette, Goa, India

Product:
Apo – Quinapril

Active Ingredient:
Quinapril hydrochloride 21.664mg equivalent to 20mg quinapril

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer:
Lupin Limited, Verna Industrial Area, Verna, Salcette, Goa, India

Product:
Apo – Quinapril

Active Ingredient:
Quinapril hydrochloride 5.416mg equivalent to 5mg quinapril

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer:
Lupin Limited, Verna Industrial Area, Verna, Salcette, Goa, India

Product:
Bicalox

Active Ingredient:
Bicalutamide 50mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Douglas Pharmaceuticals Limited

Manufacturer:
Douglas Manufacturing Limited, Lincoln, Auckland

Product:
Cephalexin ABM

Active Ingredient:
Cefalexin monohydrate equivalent to 250mg Cefalexin anhydrous

Dosage Form:
Capsule

New Zealand Sponsor:
ABM Pharma Limited

Manufacturer:
Lupin Limited, Mandideep, District Raisen, Madhya Pradesh, India

Product:
Cephalexin ABM

Active Ingredient:
Cefalexin monohydrate equivalent to 500mg Cefalexin anhydrous

Dosage Form:
Capsule

New Zealand Sponsor:
ABM Pharma Limited

Manufacturer:
Lupin Limited, Mandideep, District Raisen, Madhya Pradesh, India

Product:
Fluorescein Novartis

Active Ingredient:
Fluorescein sodium 500mg

Dosage Form:
Solution for injection

New Zealand Sponsor:
Novartis New Zealand Limited

Manufacturer:
B Braun Melsungen AG, Berlin, Germany

Product:
Oraqix Periodontal Gel

Active Ingredients:
Lidocaine 25mg/g
Prilocaine 25mg/g



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2008, No 76


Gazette.govt.nz PDF NZ Gazette 2008, No 76





✨ LLM interpretation of page content

🏥 Appointments to Whanganui District Health Board

🏥 Health & Social Welfare
21 April 2008
Appointments, District Health Board, Whanganui, Deputy Chairperson
  • Nancy Te Urumanao Tuaine, Appointed member of the board
  • Ormond Brian Stock, Appointed deputy chairperson of the board

  • HON DAVID CUNLIFFE, Minister of Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
Medicines, Distribution, Consent, Medicines Act 1981
  • Minister of Health